SCHEMBL6401397

SCHEMBL6401397

COC(=O)NC1CCc2ccc(OC)cc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.49
ACHE P22303 3/20 0.49
MTNR1A P48039 6/20 0.48
MTNR1B P49286 5/20 0.48
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
LMNA P02545 1/20 0.46
POLB P06746 1/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
HTR2C P28335 1/20 0.45
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
METAP1 P53582 1/20 0.42
NQO2 P16083 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401395 1.00 CYP19A1 (0.49) CYP19A1ACHEMTNR1AMTNR1BKDM4E
SCHEMBL7272139 0.90 LMNA (0.58) CYP19A1ACHEMTNR1AMTNR1BKDM4E
SCHEMBL8765833 0.86 ACHE (0.58) CYP19A1ACHEMTNR1AMTNR1BLMNA
SCHEMBL7280376 0.86 MTNR1A (0.52) CYP19A1ACHEMTNR1AMTNR1BNQO2
SCHEMBL12256769 0.85 SMN1; SMN2 (0.53) ACHEKDM4EMAPTLMNAPOLB
Ethylene SCHEMBL8765917 0.84 ACHE (0.56) CYP19A1ACHEMTNR1AMTNR1BLMNA
SCHEMBL8307518 0.84 KDM4E (0.43) KDM4EMAPTLMNAPOLBNPC1
SCHEMBL345475 0.78 ACHE (0.51) CYP19A1ACHEMTNR1AMTNR1BCA1
SCHEMBL1877585 0.77 ACHE (0.52) CYP19A1ACHEMTNR1AMTNR1BKDM4E
SCHEMBL7979383 0.77 CYP19A1 (0.55) CYP19A1ACHEMTNR1AMTNR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050153408-A1 7-substituted-2-tetralone or bisulfite adduct is reduced microorganism (Candida) to optically active 7-substituted-2-tetralol;sulfonyl group is introduced to hydroxy group to form optically active 7-substituted-2-sulfonyloxytetralin; nitrogen substituent is introduced via ammonia; industrial scale KANEKA CORPORATION (JP) 2005-07-14 US disclosed
EP-1457570-A1 PROCESS FOR PREPARATION OF 2-AMINOTETRALIN DERIVATIVES AND INTERMEDIATES THEREOF KANEKA CORPORATION (JP) 2004-09-15 EP disclosed